Sherlock Biosciences

Sherlock Biosciences Raises $80M in Series B Financing

The company will use the funding to develop diagnostic tests based on CRISPR and synthetic biology that can operate without complex instrumentation.

Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests

Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.

Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk

LogicInk said it will use the CRISPR technology to develop an instrument-free diagnostic biosensor for the detection of SARS-CoV-2.

Sherlock Bio Foundation Licenses CRISPR Tech to Cooper International, United PPE for COVID-19 Tests

The agreements will increase access to testing in Asia through United PPE and in the Middle East through Cooper International, the foundation said.

In Brief This Week: OpGen, Hologic, Exact Sciences, Thermo Fisher, and More

News items for the in vitro diagnostics industry for the week of Jan. 4, 2021.

Dec 28, 2020

COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020

Dec 16, 2020

Sherlock Biosciences Receives $5M Gates Foundation Grant for COVID-19 Self-Test

Dec 4, 2020

Sherlock Biosciences Licenses US Dx Rights to CRISPR-Cas12 From Tolo Biotech

Nov 18, 2020

Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx

Sep 21, 2020

Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection

Sep 17, 2020

In Brief This Week: Illumina, Siemens Healthineers, Danaher, Abbott, and More